000 | 01927 a2200553 4500 | ||
---|---|---|---|
005 | 20250514053147.0 | ||
264 | 0 | _c20030314 | |
008 | 200303s 0 0 eng d | ||
022 | _a0195-6701 | ||
024 | 7 |
_a10.1053/jhin.2002.1287 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDupeyron, C | |
245 | 0 | 0 |
_aA clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. _h[electronic resource] |
260 |
_bThe Journal of hospital infection _cDec 2002 |
||
300 |
_a281-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdministration, Intranasal |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarrier State _xdrug therapy |
650 | 0 | 4 |
_aCross Infection _xdrug therapy |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 |
_aFeces _xmicrobiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospital Units |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aInfection Control _xmethods |
650 | 0 | 4 |
_aLength of Stay _xstatistics & numerical data |
650 | 0 | 4 |
_aLiver Diseases _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMethicillin Resistance |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMupirocin _xtherapeutic use |
650 | 0 | 4 |
_aNasopharynx _xmicrobiology |
650 | 0 | 4 |
_aParis _xepidemiology |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
650 | 0 | 4 |
_aStaphylococcus aureus _xgenetics |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCampillo, B | |
700 | 1 | _aBordes, M | |
700 | 1 | _aFaubert, E | |
700 | 1 | _aRichardet, J-P | |
700 | 1 | _aMangeney, N | |
773 | 0 |
_tThe Journal of hospital infection _gvol. 52 _gno. 4 _gp. 281-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhin.2002.1287 _zAvailable from publisher's website |
999 |
_c12278415 _d12278415 |